Navigation Links
Immune Molecule Key to Preventing Organ Rejection
Date:6/23/2008

Measuring HLA-G dimer may identify patients who need little, if any, immune suppression

MONDAY, June 23 (HealthDay News) -- An immune molecule called HLA-G dimer plays a powerful role in preventing the immune system from rejecting transplanted organs and tissue, Medical College of Georgia researchers say.

They found that HLA-G helped prolong skin graft survival in mice and are currently studying whether this molecule is at work in kidney transplant patients who don't experience organ rejection.

"This is a molecule with huge potential to regulate immune response," Dr. Anatolij Horuzsko, a reproductive immunologist at the Medical College of Georgia Center for Molecular Chaperone/Radiobiology and Cancer Virology, said in a prepared statement.

He and his colleagues found that when HLA-G dimer binds with its inhibitory receptor ILT4, it triggers a signaling pathway in which immune molecules IL-6 and STAT3 play a major role.

"Biologically, this is an interaction that requires several important suppressive molecules," said Horuzsko, corresponding author of the study, which was published online in the journal Proceedings of the National Academy of Sciences.

The researchers looked at the resulting strong signal in culture and then assessed its impact on skin graft survival in mice.

Horuzsko and colleagues believe HLA-G dimer's action can be boosted in order to suppress immune activity in people with organ transplants and autoimmune diseases, and turned down in order to increase immune system activity against tumors. Measuring levels of HLA-G dimer may also help doctors identify transplant patients who require little, if any, immune system suppression.

More information

The MedlinePlus Medical Encyclopedia has more about transplant rejection.



-- Robert Preidt



SOURCE: Medical College of Georgia, news release, June 16, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Nasal spray using bodys immune system provides hope of cure for common cold
2. Immune Design Announces $18 Million Series A Financing
3. Autoimmune Disease Treatment May Not Dampen Immune System
4. Immune molecule that plays a powerful role in avoiding organ rejection identified
5. Specific location of the TRAF1/C5 gene associated with multiple autoimmune diseases
6. TB treatment for the elderly likely requires a boost to immune response
7. FDA Starts Safety Review of Autoimmune Disorder Drugs
8. OHSU Cancer Institute finds that drug stimulated immune system in prostate cancer
9. Weizmann Institute scientists develop a new approach to treating autoimmune disease
10. Cell-Mediated Immunity and Anti-HLA Antibody Tests Provide Insight to Immune Response in Renal Transplant Patients
11. Multiple Independent Studies Report on Use of Cylexs Immune Cell Function Assay in Postoperative Monitoring of Kidney, Liver, and Heart Transplant Recipients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... ... ... CURE Media Group , the nation’s leading digital and print media ... Angels to expand outreach and emotional support for patients of all ages battling ... lifeline to patients and families facing the challenges of cancer diagnosis and treatment,” said ...
(Date:5/5/2016)... ... May 05, 2016 , ... If you don’t mind a bit ... skin, you may want to consider a treatment that some have called the next ... P.C. , Microneedling, also known as skin needling, is a procedure using a ...
(Date:5/5/2016)... ... ... Dermatologic surgeons performed nearly 10 million medically necessary and cosmetic procedures in ... The results of the 2015 ASDS Survey on Dermatologic Procedures released today reveal a ... growing popularity of soft-tissue fillers and body sculpting procedures. , For the fourth ...
(Date:5/5/2016)... ... May 05, 2016 , ... MAP Health Management, LLC, ... that Enlightened Solutions has joined the Premier Outcomes-Driven Provider Network. By becoming a ... their patients being treated for substance use. , Enlightened Solutions was founded by ...
(Date:5/5/2016)... GA (PRWEB) , ... May 05, 2016 , ... Liposuction ... (FDRS) 2016 Conference in St. Louis, Missouri at the Marriot St. Louis Airport Hotel. ... Byrd was chosen to address the conference about her unique specialization in treating Lipedema. ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... -- According to market research "Global Computed Tomography ... 2022 - Industry Insights by Slice Type (High, Mid and ... P&S Market Research, the global computed tomography market ... expected to grow at a CAGR of 5.0% during 2016-2022. ... expected to witness the faster growth, CAGR of 5.3%, during ...
(Date:5/4/2016)... New Jersey , May 4, 2016 ... its successful completion of an alternative public offering (APO). ... wholly owned operating company, Valeritas, Inc. and a private ... common stock at $5.00 per share. Under ... on May 3, 2016, Valeritas Holdings, Inc. will trade ...
(Date:5/4/2016)... Research and Markets has ... Myeloid Leukemia Market and Competitive Landscape Highlights ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ) ... Competitive Landscape Highlights 2016, provides comprehensive insights ... Myeloid Leukemia epidemiology, Acute Myeloid Leukemia market ...
Breaking Medicine Technology: